Skip to main content

Table 3 Risk of recurrence/death per 1 U/ml CA-125 3 and 6 months after the treatment

From: Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer

Risk of

Time after treatment

HR

95%CI

P

Recurrence

3 months

1.083

1.05–1.12

< 0.0001

6 months

1.018

1.01–1.03

< 0.0001

Death

3 months

1.08

1.03–1.13

0.0007

6 months

1.02

1.01–1.03

0.0001